A winning strategy is essential to reach or accomplish goals in pharmaceutical industry. However, maintaining the excellence of Strategic Drug Development Services is a necessary stipulation for the Strategic evolution for Pharma companies. The technologies leading to Pharmaceutical regulatory strategy and Pharmaceutical strategic developments are at the limits of human knowledge. The huge size of the companies, organizations and the complexities of their technologies and processes present many challenges. On the other hand, strategy development and distribution system is highly costly to implement. The effective Pharma strategies can help to generate business exposure, relationship building, and market research. Thus, they are important initiatives to boom overall business in the long term.
For the pharmaceutical industry managing supply chain risk has never been a higher priority
One of the most important tasks of any regulatory body is to ensure that pharmaceutical products are developed in accordance with the localregional regulatory requirements
You are probably alltoofamiliar with the rigmarole of strategic planning situational analyses and spreadsheets slide decks and strategy reviews
The past two years have shone a bright light on the global pharmaceutical industry Perhaps more so than ever before the worlds eyes have been watching closely what may come and of course the next blockbuster product
COVID has posed an unprecedented threat to the health and economy globally since its first detection in December with more than million cases and million deaths as of February
Its been nearly two years since the outbreak of COVID began and were still in the midst of enormous disruptions to the worlds economies businesses education and peoples lives
As companies from Roche to Merck demonstrate successful adaptation begins with a shared vision of the future business model But therein lies the problem What is a business model Despite it being peppered over every meeting and filling the media there is no agreement amongst either academics or executives about the definition of this ubiquitous term
Every life science company is eager to find and absorb industry best practices and for good reason In a business environment that is changing quickly no firm can afford to be left behind and relying on internal experience and lessons is too slow It is essential to imitate as well as to innovate
Latest figures show that China is the second pharmaceutical market in the world after the United States with an overall value amounting to about billion dollars in
The first Biosimilar was approved in the year in the European Union and since then there have been more than biosimilar drugs that have been approved Not surprisingly there has been phenomenal growth in the biosimilars market an Assocham report states that the global biosimilars market is estimated to reach US billion by while the Indian biosimi...
